ELIZABETH SAYERS: Open Payments
NPI 1922025725 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 13 payments from 9 companies in 2025. Trend: 2023 $413 · 2024 $1,244 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $78 |
| Lilly USA, LLC | 2 | $37 |
| Madrigal Pharmaceuticals | 1 | $23 |
| Dexcom, Inc. | 1 | $22 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
| Abbott Laboratories | 1 | $19 |
| Ascendis Pharma Endocrinology Inc | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $16 |
Products named: Rybelsus, MOUNJARO, Ozempic, REZDIFFRA, Dexcom G6 Transmitter, t:slim X2 Insulin Pump with Control-IQ, FREESTYLE LIBRE 3, Yorvipath.
Industry payments across MO — which companies pay providers there.
